# OnCo record paper-relevance-rituximab-lenalidomide-follicular-lymphoma-morschhauser-nejm-2018 (paper). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/key-papers/paper-relevance-rituximab-lenalidomide-follicular-lymphoma-morschhauser-nejm-2018/>
  a schema:ScholarlyArticle ;
  onco:kind "paper" ;
  schema:identifier "paper-relevance-rituximab-lenalidomide-follicular-lymphoma-morschhauser-nejm-2018" ;
  schema:name "RELEVANCE: rituximab plus lenalidomide in advanced untreated follicular lymphoma"@en ;
  schema:description "A chemotherapy-free combination of rituximab and lenalidomide worked as well as rituximab with chemotherapy for untreated follicular lymphoma, though not better, with different side effects."@en ;
  schema:url <https://onco.cc/key-papers/paper-relevance-rituximab-lenalidomide-follicular-lymphoma-morschhauser-nejm-2018/> ;
  schema:dateModified "2026-09-22"^^xsd:date ;
  schema:citation <https://doi.org/10.1056/NEJMoa1805104>, <https://pubmed.ncbi.nlm.nih.gov/30184451/> ;
  schema:sameAs <https://doi.org/10.1056/NEJMoa1805104> ;
  schema:datePublished "2018"^^xsd:gYear ;
  schema:author "Morschhauser F, Fowler NH, Feugier P, et al." ;
  onco:cancers <https://onco.cc/cancers/follicular-lymphoma/> ;
  onco:drugs <https://onco.cc/drugs/lenalidomide/>, <https://onco.cc/drugs/rituximab/> ;
  onco:trials <https://onco.cc/trials/relevance/> ;
  onco:journals <https://onco.cc/journals/nejm/> .